Cytophage Technologies Ltd.

Research Cytophage Technologies Ltd. (CYTO) on Bullrun: market cap CAD 338.43K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCYTO
• ExchangeV
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCAD
• Market capCAD 338.43K
• Financial periodQ3 2025
• Net income-CAD 1.04M
• Free cash flow-CAD 809.44K

Valuation Snapshot

latest market cap is CAD 338.43K.

About Cytophage Technologies Ltd.

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name.

Frequently asked questions

What is Cytophage Technologies Ltd.'s market cap?

Cytophage Technologies Ltd.'s market capitalization is CAD 338.43K.

What does Cytophage Technologies Ltd. do?

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name;